KB

Krishnamoorthy Balagurunathan

Active Director Director DIN 09393621
DIN 09393621 First appointment Nov 2021 Primary industry Veterinary
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Krishnamoorthy Balagurunathan

Data last updated:

Krishnamoorthy Balagurunathan is a Director at Cure Is Here Private Limited (since 2021). The company operates in Veterinary.

DIN 09393621
Primary Designation Director
Industry Veterinary
First Appointment 10 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cure Is Here Private Limited U85200TN2021PTC147792
Director10 Nov 20212021Active

Board colleagues of Krishnamoorthy Balagurunathan

NameDINCompanyDesignation
Chellapillai Jayalakshmi09393622Cure Is Here Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cure Is Here Private Limited
Premium access

Shareholding and investment profile for Krishnamoorthy Balagurunathan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishnamoorthy Balagurunathan

Krishnamoorthy Balagurunathan currently holds 1 directorship: Cure Is Here Private Limited (Director, since 10 Nov 2021).

Krishnamoorthy Balagurunathan was first appointed on 10 Nov 2021 as Director at Cure Is Here Private Limited.

The current boards of Krishnamoorthy Balagurunathan's companies include Chellapillai Jayalakshmi (Cure Is Here Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available